Squarepoint Ops LLC Day One Biopharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.03 - $17.69 $2.24 Million - $3.3 Million	186,484 New	186,484 $2.57 Million
Q4 2023 Feb 14, 2024	SELL	$9.68 - $15.37 $1.41 Million - $2.24 Million	-145,859 Reduced 90.16%	15,927 $232,000
Q2 2023 Aug 14, 2023	SELL	$11.74 - $14.47 $730,122 - $899,903	-62,191 Reduced 27.77%	161,786 $1.93 Million
Q1 2023 May 15, 2023	BUY	$12.75 - $23.41 $2.46 Million - $4.52 Million	193,161 Added 626.82%	223,977 $2.99 Million
Q4 2022 Feb 14, 2023	BUY	$18.77 - $22.0 $578,416 - $677,952	30,816 New	30,816 $663,000
Q3 2021 Nov 15, 2021	SELL	$20.0 - $27.92 $378,540 - $528,441	-18,927 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.0 - $23.69 $359,613 - $448,380	18,927 New	18,927 $431,000

178

84M

144K

218K

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $924M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.